How Sunday Housecall with Dr. Samadi is making waves online

The state of Healthcare in the United States has never been more intricate, confusing and complicated. Not only are the practical aspects of billing and insurance daunting, the latest treatments and options leave many patients feeling completely overwhelmed. It’s for this reason that Dr. Samadhi started his weekly broadcast “Sunday Housecall”, which is available online completely free of charge.

This brand new program released in 2017 takes classic health news programs and brings them into the 21st century. Not only is it available for streaming online, the show is completely integrated with social media, allowing users to interact in real time. No matter what your social platform, or even if you simply want to watch the show on his website, Dr. Samadi has every user covered, and David Samadi on Facebook.

Unlike traditional medical TV shows, “Sunday Housecall with Dr. David Samadi” covers topics both related to treatment, as well as overall trends in the industry. On a week to week basis the show shifts from covering the latest in medical advancements, while other weeks cover more procedural and systemic facets of American health care. This approach allows many topics to be covered all at once and seeks to answer as many questions as possible during the weekly time slot.

In fact, answering questions is so ingrained into the show that users can respond and ask questions in real time. Rather than asking for e-mails after the show and following up next week, Dr. Samadi is taking call and e-mails and providing answers in real time, not unlike successful talk radio programs, and https://www.healthgrades.com/physician/dr-david-samadi-337fr.

Dr. Samadi isn’t alone in his mission. On most broadcasts, he is joined by special guests, who can provide supplemental and specialized insight in their field. This approach brings a new set of perspectives to the show, ensuring that viewers can get insight and information from every source available, and more information click here.

Because guests are only an occasional occurrence on the show, they can be properly vetted; the show can go on without them, and there will never be a guest invited simply for sake of conversation; only genuine talents with medical insights to share will be given the stage.

Altogether, Sunday Housecall delivers everything you would expect from a medical show targeted to the average American, all while introducing new aspects and technology. Never before have we seen a show that is so customizable and so intractable; it will be interesting to see just how far this show can go, and how many viewers Dr. Samadi can reach, and David Samadi’s lacrosse camp.

Eric Lefkofksy Wants to Change Cancer Treatment with Personalized Data

Heidi Harris recently published an article with Tech News Spy called “Tempus, Eric Lefkofsky, and the Rise of Data-Enabled Precision Medicine”. The article discusses Tempus, the brain child of co-founder Eric Lefkofsky, who wants the company to be the thought leader in data-enabled precision medical treatment.

 

The company was born out of Lefkofsky’s personal experience with the lack of technology in cancer treatment. After his wife was diagnosed with cancer, he found that the treatment process was often painful. It was painful not just because of the treatment itself, but because of the lack of information and technology available for physicians.

 

Lefkofsky found a gap in data collection and technology that can interpret it. The huge amounts of data being created about treatment and the patients prevented should allow the doctors to provide individualized treatment plans. However, the lack of technology prevented physicians from being able to use all of that information accurately and what Eric knows.

 

Tempus seeks to fill that gap, providing real-time, data-driven treatment with “cutting edge genomic sequencing and analysis methods.” This allows the doctors to have an in-depth understanding of each patient’s tumor as well as providing access to the largest library of clinical and molecular data. The operating system and analytics provides information to the doctors to focus on actionable data. By allowing the physician to fight the disease from the molecular and cellular level, Tempus will provide critical information for the doctors as well as the patients. Even the treatment can be tested on synthetic models to screen the therapies before patient use to ensure higher rates of treatment success and his Facebook.

 

Mr. Lefkofsky has been drawn to the entrepreneurial lifestyle since he sold carpet when he was a student at the University of Michigan. After law school, he co-founded a variety of companies like InnerWorkings, Echo Global Logistics, Mediabank, and Mediaocea. Tempus, however is closer to his heart after his wife’s personal experience with cancer treatment and more information click here.

 

Mr. Lefkofsky has also taught at a variety of schools. He is currently teaching at the Booth School of Business at the University of Chicago. There he teaches courses on how to build technology based businesses and entrepreneurship and Eric’s lacrosse camp.

Eric Lefkofsky Uses Data to Help Cure Cancer

Tempus co-founder Eric Lefkofsky planned to be done starting businesses. Lefkofsky has already co-founded Groupon, as well as a number of other technology companies. After leaving his job as Groupon CEO, he plans to do something different.

Everything changed when his wife Elizabeth was diagnosed with breast cancer. After going with her to treatments and consultations with doctors, Lefkofsky realized how little information is available for doctors to work with when treating cancer. He felt that all available data about cancer should be in one place, so that doctors could easily consult it and make an informed decision. It occurred to Lefkofsky that this was a problem he knew how to solve, and Tempus was born and learn more about Eric.

Along with his business partner, Brad Keywell, Lefkofsky began by forming partnerships with health organizations such as the Mayo Clinic, Northwestern University, and the University of Chicago. Oncologists at these organizations sent their patients to Lefkofsky and Keywell, who built a library of patient information and created an operating system that doctors could use to access it. They plan to grow their data library as much as they can. This way doctors can find patients with the same specific mutations as their current patients, and look at what treatments have worked in the past in order to make informed decisions and more information click here.

Lefkofsky has a major advantage with Tempus. Unlike similar companies, Tempus doesn’t need to rely on any outside funding. Lefkofsky’s net worth is $1.7 billion, and he has funded Tempus completely on his own. He believes this is the most important work he’s ever done, and is willing to invest as much as it takes to keep Tempus alive and self-sufficient.

Lefkofsky has started many successful businesses before this one. The best-known is Groupon. He is also co-founder of Uptake Technologies, MediaOcean, Echo Global Logistics, and InnerWorkings. These are all successful technology companies.

Lefkofsky was actively involved in helping others even before starting Tempus. The Lefkofsky Family Foundation, which he started with Elizabeth, works to advance important programs and research that impact the world. He is also a Trustee at Lurie Children’s Hospital of Chicago.

More visit: http://fortune.com/2017/05/03/brainstorm-health-cancer-data/